SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-019872
Filing Date
2023-05-26
Accepted
2023-05-26 08:39:42
Documents
14
Period of Report
2023-05-22
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20230522.htm   iXBRL 8-K 45812
2 EX-99.1 exhibit991-warwickdivestur.htm EX-99.1 10826
3 EX-99.2 exhibit992bvswarwickprofor.htm EX-99.2 332536
  Complete submission text file 0001628280-23-019872.txt   564959

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20230522.xsd EX-101.SCH 1902
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20230522_lab.xml EX-101.LAB 25848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20230522_pre.xml EX-101.PRE 13582
8 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20230522_htm.xml XML 11878
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 23963203
SIC: 3841 Surgical & Medical Instruments & Apparatus